This contract expires in 107 days (Sep 26, 2026).

Browse related active opportunities

COST PLUS FIXED FEE

RHO FEDERAL SYSTEMS DIVISION INC - INTEGRATED SAFETY SUMMARY REPORT OF CLINICAL STUDIES ASSESSING SAFETY OF INFLUENZA VACCINES ADMINISTERED WITH AS03 OR MF59 ADJUVANT.

PIID: 75A50122F33004
Signed Date: Oct 22, 2025Effective Date: Sep 27, 2022End Date: Closes in 107 days
Award $
$3.0M
Vendor
RHO FEDERAL SYSTEMS DIVISION INC
NAICS
541715
Signed Date
Oct 22, 2025

Key Details

Dollars Obligated
$3.0M
Base & All Options
Awarding Sub-Agency
Office of Assistant Secretary for Preparedness and Response
Product Service Code
AN11 - HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH
Extent Competed
FULL AND OPEN COMPETITION
Place of Performance
DURHAM, NC, 277137444, CD-NC-04

Description

INTEGRATED SAFETY SUMMARY REPORT OF CLINICAL STUDIES ASSESSING SAFETY OF INFLUENZA VACCINES ADMINISTERED WITH AS03 OR MF59 ADJUVANT.

Context & Analysis

On Oct 22, 2025, Department of Health and Human Services obligated $2,983,502 to RHO FEDERAL SYSTEMS DIVISION INC for integrated safety summary report of clinical studies assessing safety of influenza vaccines administered with as03 or mf59 adjuvant.. The award is classified under NAICS 541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) and issued as a cost plus fixed fee contract. Competition extent: full and open competition. Performance is located in DURHAM, NC. The contract is scheduled through Sep 26, 2026 — approximately 4 months remaining. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541715 — related awards are listed below.

Contractor Information

UEI: XCPKWEM58CV5
CAGE Code: 8A1W7
Location: DURHAM, NC

Stay Updated

Get notified about new opportunities matching your interests.

Related